HCAT saw its Momentum Indicator move below the 0 level on October 16, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 90 similar instances where the indicator turned negative. In 83 of the 90 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
The 50-day moving average for HCAT moved below the 200-day moving average on October 13, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HCAT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.
HCAT broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 45 of 64 cases where HCAT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 70%.
HCAT moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for HCAT crossed bullishly above the 50-day moving average on October 14, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 88%.
Following a +1.14% 3-day Advance, the price is estimated to grow further. Considering data from situations where HCAT advanced for three days, in 178 of 244 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.
The Aroon Indicator entered an Uptrend today. In 90 of 106 cases where HCAT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 85%.
The Tickeron Valuation Rating of 23 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.321) is normal, around the industry mean (7.432). HCAT has a moderately low P/E Ratio (0.000) as compared to the industry average of (46.656). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.133). Dividend Yield (0.000) settles around the average of (0.010) among similar stocks. P/S Ratio (0.429) is also within normal values, averaging (6.065).
The Tickeron Price Growth Rating for this company is 56 (best 1 - 100 worst), indicating fairly steady price growth. HCAT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HCAT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 97, placing this stock worse than average.
RDVT moved below its 50-day moving average on October 16, 2026 date and that indicates a change from an upward trend to a downward trend. In 36 of 41 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 88%.
The Momentum Indicator moved below the 0 level on October 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on RDVT as a result. In 69 of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 75%.
The Moving Average Convergence Divergence Histogram (MACD) for RDVT turned negative on October 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In 41 of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at 77%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RDVT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a +0.98% 3-day Advance, the price is estimated to grow further. Considering data from situations where RDVT advanced for three days, in 221 of 291 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
RDVT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 185 of 233 cases where RDVT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 79%.
The Tickeron Profit vs. Risk Rating rating for this company is 26 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. RDVT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 54 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 62 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 77 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (11.299) is normal, around the industry mean (51.922). P/E Ratio (69.237) is within average values for comparable stocks, (82.636). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.135). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (11.249) is also within normal values, averaging (70.810).
HCAT | RDVT | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 75 | 64 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 23 Undervalued | 77 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 26 | |
SMR RATING 1..100 | 99 | 54 | |
PRICE GROWTH RATING 1..100 | 56 | 36 | |
P/E GROWTH RATING 1..100 | 100 | 62 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
HCAT's Valuation (23) in the null industry is somewhat better than the same rating for RDVT (77) in the Packaged Software industry. This means that HCAT’s stock grew somewhat faster than RDVT’s over the last 12 months.
RDVT's Profit vs Risk Rating (26) in the Packaged Software industry is significantly better than the same rating for HCAT (100) in the null industry. This means that RDVT’s stock grew significantly faster than HCAT’s over the last 12 months.
RDVT's SMR Rating (54) in the Packaged Software industry is somewhat better than the same rating for HCAT (99) in the null industry. This means that RDVT’s stock grew somewhat faster than HCAT’s over the last 12 months.
RDVT's Price Growth Rating (36) in the Packaged Software industry is in the same range as HCAT (56) in the null industry. This means that RDVT’s stock grew similarly to HCAT’s over the last 12 months.
RDVT's P/E Growth Rating (62) in the Packaged Software industry is somewhat better than the same rating for HCAT (100) in the null industry. This means that RDVT’s stock grew somewhat faster than HCAT’s over the last 12 months.
| HCAT | RDVT | |
|---|---|---|
| RSI ODDS (%) | N/A | N/A |
| Stochastic ODDS (%) | 1 day ago 70% | 1 day ago 72% |
| Momentum ODDS (%) | 1 day ago 90% | 1 day ago 75% |
| MACD ODDS (%) | N/A | 1 day ago 77% |
| TrendWeek ODDS (%) | 1 day ago 87% | 1 day ago 74% |
| TrendMonth ODDS (%) | 1 day ago 88% | 1 day ago 76% |
| Advances ODDS (%) | 11 days ago 73% | 18 days ago 76% |
| Declines ODDS (%) | 4 days ago 87% | 3 days ago 71% |
| BollingerBands ODDS (%) | 1 day ago 82% | 1 day ago 88% |
| Aroon ODDS (%) | 1 day ago 85% | 1 day ago 79% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
HCAT’s FA Score shows that 1 FA rating(s) are green while RDVT’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
HCAT’s TA Score shows that 5 TA indicator(s) are bullish while RDVT’s TA Score has 4 bullish TA indicator(s).
HCAT (@Services to the Health Industry) experienced а -2.54% price change this week, while RDVT (@Packaged Software) price change was -7.24% for the same time period.
The average weekly price growth across all stocks in the @Services to the Health Industry industry was -4.54%. For the same industry, the average monthly price growth was -4.32%, and the average quarterly price growth was +10.20%.
The average weekly price growth across all stocks in the @Packaged Software industry was -5.69%. For the same industry, the average monthly price growth was -6.22%, and the average quarterly price growth was -2.11%.
HCAT is expected to report earnings on Nov 10, 2026.
RDVT is expected to report earnings on Nov 10, 2026.
This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.
@Packaged Software (-5.69% weekly)Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FLDR | 49.98 | 0.06 | +0.12% |
| Fidelity Low Duration Bond Factor ETF (FLDR) | |||
| MYHB | 24.64 | -0.03 | -0.11% |
| State Street My2028 High Yield Corporate Bond ETF (MYHB) | |||
| FTBD | 47.30 | -0.06 | -0.14% |
| Fidelity Tactical Bond ETF (FTBD) | |||
| SBAR | 25.06 | -0.14 | -0.56% |
| Simplify Barrier Income ETF | |||
| AFSM | 39.03 | -0.61 | -1.54% |
| First Trust Active Factor Small Cap ETF (AFSM) | |||
A.I.dvisor indicates that over the last year, HCAT has been loosely correlated with KVYO. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if HCAT jumps, then KVYO could also see price increases.
| Ticker / NAME | Correlation To HCAT | 1D Price Change % | ||
|---|---|---|---|---|
| HCAT | 100% | -4.17% | ||
| KVYO - HCAT | 47% Loosely correlated | -5.58% | ||
| EVCM - HCAT | 46% Loosely correlated | -1.26% | ||
| RDVT - HCAT | 45% Loosely correlated | -4.11% | ||
| CPAY - HCAT | 43% Loosely correlated | -1.57% | ||
| COIN - HCAT | 43% Loosely correlated | -5.79% | ||
More | ||||
A.I.dvisor indicates that over the last year, RDVT has been loosely correlated with LSPD. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if RDVT jumps, then LSPD could also see price increases.
| Ticker / NAME | Correlation To RDVT | 1D Price Change % | ||
|---|---|---|---|---|
| RDVT | 100% | -4.11% | ||
| LSPD - RDVT | 53% Loosely correlated | -2.94% | ||
| PCOR - RDVT | 52% Loosely correlated | -2.76% | ||
| PD - RDVT | 51% Loosely correlated | -6.32% | ||
| QTWO - RDVT | 51% Loosely correlated | -0.39% | ||
| NOW - RDVT | 51% Loosely correlated | -4.44% | ||
More | ||||